Consolidation Clinical Trials

3 recruitingLast updated: May 4, 2026

Consolidation Trials at a Glance

7 actively recruiting trials for consolidation are listed on ClinicalTrialsFinder across 6 cities in 6 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Belo Horizonte, Botucatu, and Bron. Lead sponsors running consolidation studies include Hospital Alemão Oswaldo Cruz, Hospital Israelita Albert Einstein, and Hospices Civils de Lyon.

Browse consolidation trials by phase

Treatments under study

About Consolidation Clinical Trials

Looking for clinical trials for Consolidation? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Consolidation trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Consolidation clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 17 of 7 trials

Recruiting
Not Applicable

Evaluation of the Efficacy of Diagnostic Support Algorithms in Chest X-rays- LuAna Trial

PneumothoraxPleural EffusionLung Injury+3 more
Hospital Israelita Albert Einstein1,470 enrolled1 locationNCT06686251
Recruiting
Not Applicable

Theories of Working Memory and Consolidation/RECOnsolidation in the Process of Resorption of Post-traumatic Symptoms.

Eye Movement Desensitization and ReprocessingStress Disorders, Post-TraumaticWorking Memory+5 more
University of Lorraine150 enrolled1 locationNCT06469333
Recruiting
Not Applicable

Human Learning of New Structured Information Across Time and Sleep

SleepHumansConsolidation+1 more
University of Pennsylvania105 enrolled1 locationNCT05910762
Recruiting
Phase 2

Combination of Concurrent Chemoradiotherapy With Surufatinib and Tislelizumab in Patients With Locally Advanced Non-Small Cell Lung Cancer

Non-small Cell Lung CancerTislelizumabConcurrent Chemoradiotherapy+2 more
Sun Yat-sen University80 enrolled1 locationNCT07086456
Recruiting

Sleep and Rehearsal-Driven Memory in Epilepsy

EpilepsyMemory Consolidation
Hospices Civils de Lyon20 enrolled1 locationNCT06967935
Recruiting
Not Applicable

Chemoradiation and Consolidation Chemotherapy With or Without Oxaliplatin for Distal Rectal Cancer and Watch and Wait

Rectal CancerConsolidation
Hospital Alemão Oswaldo Cruz216 enrolled24 locationsNCT05000697
Recruiting
Phase 2

Tislelizumab Consolidation Therapy After Radiotherapy or Sequential Chemoradiation in Locally Advanced NSCLC Patients

Non-small Cell Lung CancerConsolidation ImmunotherapyRadiotherapy or Sequential Chemoradiation
Peking University Cancer Hospital & Institute20 enrolled1 locationNCT05758116